-
1
-
-
0034762203
-
The Raf/MEK/ERK pathway: new concepts of activation
-
Peyssonnaux C., Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 2001, 93(1-2):53-62.
-
(2001)
Biol. Cell
, vol.93
, Issue.1-2
, pp. 53-62
-
-
Peyssonnaux, C.1
Eychene, A.2
-
2
-
-
18444374405
-
Mutations of the BRAF gene in human cancer
-
Davies H., et al. Mutations of the BRAF gene in human cancer. Nature 2002, 417(6892):949-954.
-
(2002)
Nature
, vol.417
, Issue.6892
, pp. 949-954
-
-
Davies, H.1
-
3
-
-
79959795786
-
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
-
Chapman P.B., et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med 2011, 364(26):2507-2516.
-
(2011)
N. Engl. J. Med
, vol.364
, Issue.26
, pp. 2507-2516
-
-
Chapman, P.B.1
-
4
-
-
84875706825
-
Resistance to BRAF-targeted therapy in melanoma
-
Sullivan R.J., Flaherty K.T. Resistance to BRAF-targeted therapy in melanoma. Eur. J. Cancer 2013, 49(6):1297-1304.
-
(2013)
Eur. J. Cancer
, vol.49
, Issue.6
, pp. 1297-1304
-
-
Sullivan, R.J.1
Flaherty, K.T.2
-
5
-
-
84904888606
-
Systemic treatment for BRAF-mutant melanoma: where do we go next?
-
Menzies A.M., Long G.V. Systemic treatment for BRAF-mutant melanoma: where do we go next?. Lancet Oncol 2014, 15(9):e371-e381.
-
(2014)
Lancet Oncol
, vol.15
, Issue.9
, pp. e371-e381
-
-
Menzies, A.M.1
Long, G.V.2
-
6
-
-
84902008991
-
The multiple facets of drug resistance: one history, different approaches
-
Niero E.L., et al. The multiple facets of drug resistance: one history, different approaches. J. Exp. Clin. Cancer Res 2014, 33:37.
-
(2014)
J. Exp. Clin. Cancer Res
, vol.33
, pp. 37
-
-
Niero, E.L.1
-
7
-
-
84905845186
-
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years
-
Panczyk M. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J. Gastroenterol 2014, 20(29):9775-9827.
-
(2014)
World J. Gastroenterol
, vol.20
, Issue.29
, pp. 9775-9827
-
-
Panczyk, M.1
-
8
-
-
0021916585
-
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance
-
Bell D.R., et al. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J. Clin. Oncol 1985, 3(3):311-315.
-
(1985)
J. Clin. Oncol
, vol.3
, Issue.3
, pp. 311-315
-
-
Bell, D.R.1
-
9
-
-
56449108015
-
Role of microRNAs in drug-resistant ovarian cancer cells
-
Sorrentino A., et al. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol. Oncol 2008, 111(3):478-486.
-
(2008)
Gynecol. Oncol
, vol.111
, Issue.3
, pp. 478-486
-
-
Sorrentino, A.1
-
10
-
-
84903544283
-
VAV3 mediates resistance to breast cancer endocrine therapy
-
Aguilar H., et al. VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Res 2014, 16(3):R53.
-
(2014)
Breast Cancer Res
, vol.16
, Issue.3
, pp. R53
-
-
Aguilar, H.1
-
11
-
-
84863221252
-
The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis
-
Izraely S., et al. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis. Int. J. Cancer 2012, 131(5):1071-1082.
-
(2012)
Int. J. Cancer
, vol.131
, Issue.5
, pp. 1071-1082
-
-
Izraely, S.1
-
12
-
-
84922242833
-
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis
-
Izraely S., Sagi-Assif O., Klein A., Meshel T., Ben-Menachem S., Zaritsky A., et al. The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis. Int. J. Cancer 2015, 15:1296-1307.
-
(2015)
Int. J. Cancer
, vol.15
, pp. 1296-1307
-
-
Izraely, S.1
Sagi-Assif, O.2
Klein, A.3
Meshel, T.4
Ben-Menachem, S.5
Zaritsky, A.6
-
13
-
-
27744460321
-
Blood-brain barrier-specific properties of a human adult brain endothelial cell line
-
Weksler B.B., et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005, 19(13):1872-1874.
-
(2005)
FASEB J.
, vol.19
, Issue.13
, pp. 1872-1874
-
-
Weksler, B.B.1
-
14
-
-
0036433641
-
In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R
-
Unger R.E., et al. In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc. Res 2002, 64(3):384-397.
-
(2002)
Microvasc. Res
, vol.64
, Issue.3
, pp. 384-397
-
-
Unger, R.E.1
-
15
-
-
84885672794
-
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS
-
Duan H., et al. Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS. Sci. Rep 2013, 3:1687.
-
(2013)
Sci. Rep
, vol.3
, pp. 1687
-
-
Duan, H.1
-
16
-
-
0032528352
-
Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells
-
Yamamoto H., Sedgwick J.B., Busse W.W. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J. Immunol 1998, 161(2):971-977.
-
(1998)
J. Immunol
, vol.161
, Issue.2
, pp. 971-977
-
-
Yamamoto, H.1
Sedgwick, J.B.2
Busse, W.W.3
-
17
-
-
0035833247
-
RhoA is required for monocyte tail retraction during transendothelial migration
-
Worthylake R.A., et al. RhoA is required for monocyte tail retraction during transendothelial migration. J. Cell Biol 2001, 154(1):147-160.
-
(2001)
J. Cell Biol
, vol.154
, Issue.1
, pp. 147-160
-
-
Worthylake, R.A.1
-
18
-
-
17644386200
-
High-throughput microtiter assay for Hoechst 33342 dye uptake
-
Seigel G.M., Campbell L.M. High-throughput microtiter assay for Hoechst 33342 dye uptake. Cytotechnology 2004, 45(3):155-160.
-
(2004)
Cytotechnology
, vol.45
, Issue.3
, pp. 155-160
-
-
Seigel, G.M.1
Campbell, L.M.2
-
19
-
-
0142121516
-
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
-
Irizarry R.A., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264.
-
(2003)
Biostatistics
, vol.4
, Issue.2
, pp. 249-264
-
-
Irizarry, R.A.1
-
20
-
-
84884308857
-
The role of tumor necrosis factor-alpha and interferon-gamma in regulating angiomotin-like protein 1 expression in lung microvascular endothelial cells
-
Nakajima Y., Nakamura Y., Shigeeda W., Tomoyasu M., Deguchi H., Tanita T., et al. The role of tumor necrosis factor-alpha and interferon-gamma in regulating angiomotin-like protein 1 expression in lung microvascular endothelial cells. Allergol. Int 2013, 62(3):309-322.
-
(2013)
Allergol. Int
, vol.62
, Issue.3
, pp. 309-322
-
-
Nakajima, Y.1
Nakamura, Y.2
Shigeeda, W.3
Tomoyasu, M.4
Deguchi, H.5
Tanita, T.6
-
21
-
-
57649240411
-
Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop
-
Willmarth N.E., Baillo A., Dziubinski M.L., Wilson K., Riese D.J., Ethier S.P. Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop. Cell. Signal 2009, 21(2):212-219.
-
(2009)
Cell. Signal
, vol.21
, Issue.2
, pp. 212-219
-
-
Willmarth, N.E.1
Baillo, A.2
Dziubinski, M.L.3
Wilson, K.4
Riese, D.J.5
Ethier, S.P.6
-
22
-
-
84927630294
-
Transcriptional regulation of CCL20 expression
-
Zhao L., Xia J., Wang X., Xu F. Transcriptional regulation of CCL20 expression. Microbes Infect 2014, 16:864-870.
-
(2014)
Microbes Infect
, vol.16
, pp. 864-870
-
-
Zhao, L.1
Xia, J.2
Wang, X.3
Xu, F.4
-
23
-
-
84907393776
-
E-cadherin and gastric cancer: cause, consequence, and applications
-
Liu X., Chu K.M. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res. Int 2014, 2014:637308.
-
(2014)
Biomed Res. Int
, vol.2014
, pp. 637308
-
-
Liu, X.1
Chu, K.M.2
-
24
-
-
84891121245
-
Variable expression of GLIPR1 correlates with invasive potential in melanoma cells
-
Awasthi A., Woolley A.G., Lecomte F.J., Hung N., Baguley B.C., Wilbanks S.M., et al. Variable expression of GLIPR1 correlates with invasive potential in melanoma cells. Front. Oncol 2013, 3:225.
-
(2013)
Front. Oncol
, vol.3
, pp. 225
-
-
Awasthi, A.1
Woolley, A.G.2
Lecomte, F.J.3
Hung, N.4
Baguley, B.C.5
Wilbanks, S.M.6
-
25
-
-
84904684249
-
Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas
-
Liu B., Pang B., Hou X., Fan H., Liang N., Zheng S., et al. Expression of high-mobility group AT-hook protein 2 and its prognostic significance in malignant gliomas. Hum. Pathol 2014, 45(8):1752-1758.
-
(2014)
Hum. Pathol
, vol.45
, Issue.8
, pp. 1752-1758
-
-
Liu, B.1
Pang, B.2
Hou, X.3
Fan, H.4
Liang, N.5
Zheng, S.6
-
26
-
-
84904270593
-
Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer
-
Kong D., Su G., Zha L., Zhang H., Xiang J., Xu W., et al. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer. Med. Oncol 2014, 31(8):130.
-
(2014)
Med. Oncol
, vol.31
, Issue.8
, pp. 130
-
-
Kong, D.1
Su, G.2
Zha, L.3
Zhang, H.4
Xiang, J.5
Xu, W.6
-
27
-
-
33645957321
-
Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions
-
Apte R.N., Krelin Y., Song X., Dotan S., Recih E., Elkabets M., et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour-host interactions. Eur. J. Cancer 2006, 42(6):751-759.
-
(2006)
Eur. J. Cancer
, vol.42
, Issue.6
, pp. 751-759
-
-
Apte, R.N.1
Krelin, Y.2
Song, X.3
Dotan, S.4
Recih, E.5
Elkabets, M.6
-
28
-
-
84897945579
-
The role IL-1 in tumor-mediated angiogenesis
-
Voronov E., Carmi Y., Apte R.N. The role IL-1 in tumor-mediated angiogenesis. Front. Physiol 2014, 5:114.
-
(2014)
Front. Physiol
, vol.5
, pp. 114
-
-
Voronov, E.1
Carmi, Y.2
Apte, R.N.3
-
29
-
-
77956568079
-
Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens
-
Kholmanskikh O., van Baren N., Brasseur F., Ottaviani S., Vanacker J., Arts N., et al. Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int. J. Cancer 2010, 127(7):1625-1636.
-
(2010)
Int. J. Cancer
, vol.127
, Issue.7
, pp. 1625-1636
-
-
Kholmanskikh, O.1
van Baren, N.2
Brasseur, F.3
Ottaviani, S.4
Vanacker, J.5
Arts, N.6
-
30
-
-
84883889867
-
The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
-
Chen S.F., Nieh S., Jao S.W., Wu M.Z., Liu C.L., Chang Y.C., et al. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma. J. Pathol 2013, 231(2):180-189.
-
(2013)
J. Pathol
, vol.231
, Issue.2
, pp. 180-189
-
-
Chen, S.F.1
Nieh, S.2
Jao, S.W.3
Wu, M.Z.4
Liu, C.L.5
Chang, Y.C.6
-
31
-
-
79955460636
-
Notch signalling in solid tumours: a little bit of everything but not all the time
-
Ranganathan P., Weaver K.L., Capobianco A.J. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat. Rev. Cancer 2011, 11(5):338-351.
-
(2011)
Nat. Rev. Cancer
, vol.11
, Issue.5
, pp. 338-351
-
-
Ranganathan, P.1
Weaver, K.L.2
Capobianco, A.J.3
-
32
-
-
77954729225
-
A role for the JARID1B stem cell marker for continuous melanoma growth
-
Held M., Bosenberg M. A role for the JARID1B stem cell marker for continuous melanoma growth. Pigment Cell Melanoma Res 2010, 23(4):481-483.
-
(2010)
Pigment Cell Melanoma Res
, vol.23
, Issue.4
, pp. 481-483
-
-
Held, M.1
Bosenberg, M.2
-
33
-
-
84906904987
-
Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming
-
Chen G., Xu X., Zhang L., Fu Y., Wang M., Gu H., et al. Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming. Cell Res 2014, 24(9):1121-1136.
-
(2014)
Cell Res
, vol.24
, Issue.9
, pp. 1121-1136
-
-
Chen, G.1
Xu, X.2
Zhang, L.3
Fu, Y.4
Wang, M.5
Gu, H.6
-
34
-
-
84902328340
-
LIF mediates proinvasive activation of stromal fibroblasts in cancer
-
Albrengues J., Bourget I., Pons C., Butet V., Hofman P., Tartare-Deckert S., et al. LIF mediates proinvasive activation of stromal fibroblasts in cancer. Cell Rep 2014, 7:1664-1678.
-
(2014)
Cell Rep
, vol.7
, pp. 1664-1678
-
-
Albrengues, J.1
Bourget, I.2
Pons, C.3
Butet, V.4
Hofman, P.5
Tartare-Deckert, S.6
-
35
-
-
84905472298
-
MiRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells
-
Jin M., Zhang T., Liu C., Badeaux M.A., Liu B., Liu R., et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells. Cancer Res 2014, 74(15):4183-4195.
-
(2014)
Cancer Res
, vol.74
, Issue.15
, pp. 4183-4195
-
-
Jin, M.1
Zhang, T.2
Liu, C.3
Badeaux, M.A.4
Liu, B.5
Liu, R.6
-
36
-
-
84893648608
-
The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30
-
Song M.S., Rossi J.J. The anti-miR21 antagomir, a therapeutic tool for colorectal cancer, has a potential synergistic effect by perturbing an angiogenesis-associated miR30. Front. Genet 2014, 4:301.
-
(2014)
Front. Genet
, vol.4
, pp. 301
-
-
Song, M.S.1
Rossi, J.J.2
-
37
-
-
83455236760
-
MiR221/222 in cancer: their role in tumor progression and response to therapy
-
Garofalo M., Quintavalle C., Romano G., Croce C.M., Condorelli G. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr. Mol. Med 2012, 12(1):27-33.
-
(2012)
Curr. Mol. Med
, vol.12
, Issue.1
, pp. 27-33
-
-
Garofalo, M.1
Quintavalle, C.2
Romano, G.3
Croce, C.M.4
Condorelli, G.5
-
38
-
-
78650842745
-
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer
-
Chen Y., Zaman M.S., Deng G., Majid S., Saini S., Liu J., et al. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev. Res 2011, 4(1):76-86.
-
(2011)
Cancer Prev. Res
, vol.4
, Issue.1
, pp. 76-86
-
-
Chen, Y.1
Zaman, M.S.2
Deng, G.3
Majid, S.4
Saini, S.5
Liu, J.6
-
39
-
-
84902916467
-
Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer
-
Cierna Z., Mego M., Janega P., Karaba M., Minarik G., Benca J., et al. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. BMC Cancer 2014, 14:472.
-
(2014)
BMC Cancer
, vol.14
, pp. 472
-
-
Cierna, Z.1
Mego, M.2
Janega, P.3
Karaba, M.4
Minarik, G.5
Benca, J.6
-
40
-
-
71349087406
-
A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
-
Blackburn J.S., Liu I., Coon C.I., Brinckerhoff C.E. A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis. Oncogene 2009, 28(48):4237-4248.
-
(2009)
Oncogene
, vol.28
, Issue.48
, pp. 4237-4248
-
-
Blackburn, J.S.1
Liu, I.2
Coon, C.I.3
Brinckerhoff, C.E.4
-
41
-
-
84927796903
-
Molecular regulation of ovarian cancer cell invasion
-
Sun N., Zhang Q., Xu C., Zhao Q., Ma Y., Lu X., et al. Molecular regulation of ovarian cancer cell invasion. Tumour Biol 2014, 35:11359-11366.
-
(2014)
Tumour Biol
, vol.35
, pp. 11359-11366
-
-
Sun, N.1
Zhang, Q.2
Xu, C.3
Zhao, Q.4
Ma, Y.5
Lu, X.6
-
43
-
-
84898805795
-
Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer
-
Wang C., Wang L., Su B., Lu N., Song J., Yang X., et al. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer. Prostate 2014, 74(7):689-701.
-
(2014)
Prostate
, vol.74
, Issue.7
, pp. 689-701
-
-
Wang, C.1
Wang, L.2
Su, B.3
Lu, N.4
Song, J.5
Yang, X.6
-
44
-
-
77950942116
-
Chemokine-chemokine receptor axes in melanoma brain metastasis
-
Izraely S., et al. Chemokine-chemokine receptor axes in melanoma brain metastasis. Immunol. Lett 2010, 130(1-2):107-114.
-
(2010)
Immunol. Lett
, vol.130
, Issue.1-2
, pp. 107-114
-
-
Izraely, S.1
-
45
-
-
84867093457
-
The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells
-
Klein A., et al. The metastatic microenvironment: brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells. Int. J. Cancer 2012, 131(11):2509-2518.
-
(2012)
Int. J. Cancer
, vol.131
, Issue.11
, pp. 2509-2518
-
-
Klein, A.1
-
46
-
-
70350683363
-
The tumor microenvironment: the making of a paradigm
-
Witz I.P. The tumor microenvironment: the making of a paradigm. Cancer Microenviron 2009, 2(Suppl. 1):9-17.
-
(2009)
Cancer Microenviron
, vol.2
, pp. 9-17
-
-
Witz, I.P.1
-
47
-
-
84858961972
-
Premetastatic niche: ready for new therapeutic interventions?
-
Zoccoli A., et al. Premetastatic niche: ready for new therapeutic interventions?. Expert Opin. Ther. Targets 2012, 16(Suppl. 2):S119-S129.
-
(2012)
Expert Opin. Ther. Targets
, vol.16
, pp. S119-S129
-
-
Zoccoli, A.1
-
48
-
-
45549093647
-
Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis
-
Eyler C.E., Rich J.N. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J. Clin. Oncol 2008, 26(17):2839-2845.
-
(2008)
J. Clin. Oncol
, vol.26
, Issue.17
, pp. 2839-2845
-
-
Eyler, C.E.1
Rich, J.N.2
-
49
-
-
0036154828
-
The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells
-
Kim M., Turnquist H., Jackson J., Sgagias M., Yan Y., Gong M., et al. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin. Cancer Res 2002, 8(1):22-28.
-
(2002)
Clin. Cancer Res
, vol.8
, Issue.1
, pp. 22-28
-
-
Kim, M.1
Turnquist, H.2
Jackson, J.3
Sgagias, M.4
Yan, Y.5
Gong, M.6
-
50
-
-
84871880164
-
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization
-
Tirino V., et al. Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J. 2013, 27(1):13-24.
-
(2013)
FASEB J.
, vol.27
, Issue.1
, pp. 13-24
-
-
Tirino, V.1
-
51
-
-
84923248130
-
A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms
-
Cojoc M., Mäbert K., Muders M.H., Dubrovska A. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin. Cancer Biol 2015, 31C:16-27.
-
(2015)
Semin. Cancer Biol
, vol.31 C
, pp. 16-27
-
-
Cojoc, M.1
Mäbert, K.2
Muders, M.H.3
Dubrovska, A.4
-
52
-
-
84901853867
-
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance
-
Easwaran H., Tsai H.C., Baylin S.B. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. Mol. Cell 2014, 54(5):716-727.
-
(2014)
Mol. Cell
, vol.54
, Issue.5
, pp. 716-727
-
-
Easwaran, H.1
Tsai, H.C.2
Baylin, S.B.3
-
53
-
-
31844444140
-
The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research
-
Gottesman M.M., Ling V. The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 2006, 580(4):998-1009.
-
(2006)
FEBS Lett
, vol.580
, Issue.4
, pp. 998-1009
-
-
Gottesman, M.M.1
Ling, V.2
-
54
-
-
84893570326
-
Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics
-
Noguchi K., Katayama K., Sugimoto Y. Human ABC transporter ABCG2/BCRP expression in chemoresistance: basic and clinical perspectives for molecular cancer therapeutics. Pharmgenomics. Pers. Med 2014, 7:53-64.
-
(2014)
Pharmgenomics. Pers. Med
, vol.7
, pp. 53-64
-
-
Noguchi, K.1
Katayama, K.2
Sugimoto, Y.3
-
55
-
-
84925160282
-
Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts
-
Paulitschke V., Berger W., Paulitschke P., Hofstaetter E., Knapp B., Dingelmaier-Hovorka R., et al. Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts. Mol. Cancer Ther 2015, 10.1158/1535-7163.MCT-14-0701.
-
(2015)
Mol. Cancer Ther
-
-
Paulitschke, V.1
Berger, W.2
Paulitschke, P.3
Hofstaetter, E.4
Knapp, B.5
Dingelmaier-Hovorka, R.6
-
56
-
-
84904730938
-
Nanodrug delivery in reversing multidrug resistance in cancer cells
-
Kapse-Mistry S., et al. Nanodrug delivery in reversing multidrug resistance in cancer cells. Front. Pharmacol 2014, 5:159.
-
(2014)
Front. Pharmacol
, vol.5
, pp. 159
-
-
Kapse-Mistry, S.1
-
57
-
-
84888200154
-
Nanomedicine therapeutic approaches to overcome cancer drug resistance
-
Markman J.L., et al. Nanomedicine therapeutic approaches to overcome cancer drug resistance. Adv. Drug Deliv. Rev 2013, 65(13-14):1866-1879.
-
(2013)
Adv. Drug Deliv. Rev
, vol.65
, Issue.13-14
, pp. 1866-1879
-
-
Markman, J.L.1
-
58
-
-
84888205791
-
Rationally designed nanovehicles to overcome cancer chemoresistance
-
Livney Y.D., Assaraf Y.G. Rationally designed nanovehicles to overcome cancer chemoresistance. Adv. Drug Deliv. Rev 2013, 65(13-14):1716-1730.
-
(2013)
Adv. Drug Deliv. Rev
, vol.65
, Issue.13-14
, pp. 1716-1730
-
-
Livney, Y.D.1
Assaraf, Y.G.2
-
59
-
-
84888201303
-
Role of integrated cancer nanomedicine in overcoming drug resistance
-
Iyer A.K., et al. Role of integrated cancer nanomedicine in overcoming drug resistance. Adv. Drug Deliv. Rev 2013, 65(13-14):1784-1802.
-
(2013)
Adv. Drug Deliv. Rev
, vol.65
, Issue.13-14
, pp. 1784-1802
-
-
Iyer, A.K.1
-
60
-
-
84906058912
-
The role played by the microenvironment in site-specific metastasis
-
Klein-Goldberg A., Maman S., Witz I.P. The role played by the microenvironment in site-specific metastasis. Cancer Lett 2014, 352(1):54-58.
-
(2014)
Cancer Lett
, vol.352
, Issue.1
, pp. 54-58
-
-
Klein-Goldberg, A.1
Maman, S.2
Witz, I.P.3
-
61
-
-
46449130084
-
Tumor-microenvironment interactions: dangerous liaisons
-
Witz I.P. Tumor-microenvironment interactions: dangerous liaisons. Adv. Cancer Res 2008, 100:203-229.
-
(2008)
Adv. Cancer Res
, vol.100
, pp. 203-229
-
-
Witz, I.P.1
-
62
-
-
84890290450
-
New drug targets in metastatic melanoma
-
Homet B., Ribas A. New drug targets in metastatic melanoma. J. Pathol 2014, 232(2):134-141.
-
(2014)
J. Pathol
, vol.232
, Issue.2
, pp. 134-141
-
-
Homet, B.1
Ribas, A.2
-
63
-
-
84920486555
-
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
-
Lee C.I., et al. Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. Breast 2015, 24(1):3-11.
-
(2015)
Breast
, vol.24
, Issue.1
, pp. 3-11
-
-
Lee, C.I.1
-
64
-
-
84908216664
-
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential
-
Peddi P.F., Hurvitz S.A. Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential. Ther. Adv. Med. Oncol 2014, 6(5):202-209.
-
(2014)
Ther. Adv. Med. Oncol
, vol.6
, Issue.5
, pp. 202-209
-
-
Peddi, P.F.1
Hurvitz, S.A.2
-
65
-
-
84879603956
-
Metastasis: new insights into organ-specific extravasation and metastatic niches
-
Irmisch A., Huelsken J. Metastasis: new insights into organ-specific extravasation and metastatic niches. Exp. Cell Res 2013, 319(11):1604-1610.
-
(2013)
Exp. Cell Res
, vol.319
, Issue.11
, pp. 1604-1610
-
-
Irmisch, A.1
Huelsken, J.2
-
66
-
-
82255161187
-
Cross-talk between tumor cells and the microenvironment at the metastatic niche
-
Carlini M.J., De Lorenzo M.S., Puricelli L. Cross-talk between tumor cells and the microenvironment at the metastatic niche. Curr. Pharm. Biotechnol 2011, 12(11):1900-1908.
-
(2011)
Curr. Pharm. Biotechnol
, vol.12
, Issue.11
, pp. 1900-1908
-
-
Carlini, M.J.1
De Lorenzo, M.S.2
Puricelli, L.3
-
67
-
-
44349100383
-
Organ selectivity in metastasis: regulation by chemokines and their receptors
-
Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis 2008, 25(4):345-356.
-
(2008)
Clin. Exp. Metastasis
, vol.25
, Issue.4
, pp. 345-356
-
-
Ben-Baruch, A.1
-
68
-
-
44449114208
-
Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis
-
Gout S., Tremblay P.L., Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin. Exp. Metastasis 2008, 25(4):335-344.
-
(2008)
Clin. Exp. Metastasis
, vol.25
, Issue.4
, pp. 335-344
-
-
Gout, S.1
Tremblay, P.L.2
Huot, J.3
-
69
-
-
36148967681
-
Metastasis: the seed and soil theory gains identity
-
Fokas E., et al. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 2007, 26(3-4):705-715.
-
(2007)
Cancer Metastasis Rev
, vol.26
, Issue.3-4
, pp. 705-715
-
-
Fokas, E.1
|